Product Articles
Biotech Sales Email Templates That Actually Get Replies
Why most cold emails to biopharma fail, and the trigger based outreach approach that works. Ten sequences tied to real events, with subject lines that get opened.
Why most cold emails to biopharma fail, and the trigger based outreach approach that works. Ten sequences tied to real events, with subject lines that get opened.
How to calculate a biotech company’s cash runway from public filings, what the warning signs are, and why a company running low on cash is a buying signal, not a dead lead.
What it actually costs to reach a biotech buyer across twelve marketing channels, what each is good for, and the one calculation that makes them all comparable.
A full calendar of the major biotech and pharma conferences through 2027, with verified dates and venues, plus which events are worth a booth and which are not.
How to choose a CDMO without betting your program. The five types of manufacturer, the criteria that predict success, the questions to ask, and the red flags to watch.
How to choose a CRO for your clinical trial. The four delivery models, the criteria that predict success, the change order trap, and the questions to ask before you sign.
How to tell a real clinical trial result from a good press release. The concepts that decide whether a trial worked, and the phrases that mean the opposite of what they say.
Biotech companies buy when something happens, not when you call. Learn the 25 trigger events that signal a biopharma company is about to buy, and how to act first.
Every FDA designation and approval pathway in plain English. What Fast Track, Breakthrough, Priority Review, and Accelerated Approval actually get you, and what they do not.
What is driving the 2026 biopharma M&A wave, what each deal structure reveals about the buyer, and how to read an acquisition the day it breaks.